US-Germany tariff disputes deepen
Reports indicate that customs tensions between the United States and Germany are rising, as the Trump administration has initiated an investigation into Germany's drug pricing tariffs, threatening a pending trade agreement between Washington and the European Union. Germany has implemented reforms in its health insurance system aimed at reducing drug expenditure, while the U.S. Trade Representative has criticized these policies, accusing Germany of offering minimal compensation for innovative pharmaceutical products. This situation jeopardizes the stability of the trade relations between the two countries.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)